Royal Bank of Canada decreased its holdings in shares of Molina Healthcare, Inc (NYSE:MOH - Free Report) by 33.0% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 53,197 shares of the company's stock after selling 26,258 shares during the period. Royal Bank of Canada owned 0.10% of Molina Healthcare worth $7,091,000 as of its most recent SEC filing.
Other institutional investors also recently bought and sold shares of the company. Empowered Funds LLC raised its holdings in Molina Healthcare by 81.5% in the first quarter. Empowered Funds LLC now owns 40,420 shares of the company's stock worth $5,388,000 after buying an additional 18,152 shares during the last quarter. Maverick Capital Ltd. bought a new position in shares of Molina Healthcare in the first quarter worth approximately $86,081,000. Quantinno Capital Management LP grew its holdings in shares of Molina Healthcare by 43.1% during the first quarter. Quantinno Capital Management LP now owns 61,495 shares of the company's stock valued at $8,197,000 after buying an additional 18,511 shares during the last quarter. Delta Global Management LP purchased a new stake in shares of Molina Healthcare during the first quarter valued at approximately $457,000. Finally, Waverly Advisors LLC bought a new stake in shares of Molina Healthcare during the first quarter valued at approximately $595,000. 98.50% of the stock is owned by hedge funds and other institutional investors.
Insider Activity at Molina Healthcare
In other news, CAO Maurice Hebert sold 600 shares of the company's stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $191.55, for a total transaction of $114,930.00. Following the completion of the sale, the chief accounting officer owned 12,815 shares of the company's stock, valued at $2,454,713.25. This represents a 4.47% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.44% of the stock is owned by insiders.
Analyst Ratings Changes
Several equities analysts recently issued reports on MOH shares. Weiss Ratings cut Molina Healthcare from a "hold (c-)" rating to a "sell (d+)" rating in a research report on Friday, July 24th. Zacks Research raised Molina Healthcare from a "hold" rating to a "strong-buy" rating in a report on Thursday, July 23rd. UBS Group boosted their price target on Molina Healthcare from $180.00 to $202.00 and gave the stock a "neutral" rating in a research note on Friday, May 22nd. Morgan Stanley upped their price target on Molina Healthcare from $146.00 to $167.00 and gave the company an "equal weight" rating in a report on Thursday, June 4th. Finally, Barclays dropped their price objective on Molina Healthcare from $184.00 to $180.00 and set an "underweight" rating on the stock in a research report on Friday, July 24th. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, eleven have issued a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus price target of $202.44.
Check Out Our Latest Research Report on MOH
Molina Healthcare Price Performance
NYSE MOH opened at $194.58 on Wednesday. The business's fifty day moving average price is $209.87 and its 200-day moving average price is $177.77. The stock has a market capitalization of $10.16 billion, a price-to-earnings ratio of -1,080.94, a PEG ratio of 28.48 and a beta of 0.75. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.68 and a quick ratio of 1.68. Molina Healthcare, Inc has a 1-year low of $121.06 and a 1-year high of $244.89.
Molina Healthcare (NYSE:MOH - Get Free Report) last issued its quarterly earnings data on Wednesday, July 22nd. The company reported $1.51 EPS for the quarter, topping the consensus estimate of $1.39 by $0.12. The company had revenue of $10.87 billion during the quarter, compared to analyst estimates of $10.83 billion. Molina Healthcare had a positive return on equity of 3.73% and a negative net margin of 0.02%.Molina Healthcare's revenue was down 4.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $5.48 earnings per share. On average, equities analysts predict that Molina Healthcare, Inc will post 5.29 earnings per share for the current year.
About Molina Healthcare
(
Free Report)
Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.
The company traces its roots to the early 1980s, when Dr.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.
Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.